Hempacco Co., Inc. (HPCO)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 7.59 Million USD | 35.61% |
| 2022 | 5.6 Million USD | 180.68% |
| 2021 | 1.99 Million USD | 165.64% |
| 2020 | 751.27 Thousand USD | 1474.91% |
| 2019 | 47.7 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 1.45 Million USD | -36.23% |
| 2023 Q1 | 2.27 Million USD | -23.05% |
| 2023 FY | 7.59 Million USD | 35.61% |
| 2023 Q4 | 3.67 Million USD | 119.23% |
| 2023 Q3 | 1.67 Million USD | 15.26% |
| 2022 Q4 | 2.96 Million USD | 185.58% |
| 2022 Q3 | 1.03 Million USD | 82.41% |
| 2022 Q2 | 568.79 Thousand USD | -44.9% |
| 2022 FY | 5.6 Million USD | 180.68% |
| 2022 Q1 | 1.03 Million USD | 36.14% |
| 2021 Q1 | 327.38 Thousand USD | -61.7% |
| 2021 FY | 1.99 Million USD | 165.64% |
| 2021 Q4 | 758.28 Thousand USD | 78.98% |
| 2021 Q3 | 423.67 Thousand USD | -12.89% |
| 2021 Q2 | 486.36 Thousand USD | 48.56% |
| 2020 FY | 751.27 Thousand USD | 1474.91% |
| 2020 Q4 | 854.89 Thousand USD | 0.0% |
| 2019 FY | 47.7 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bright Green Corporation | 8.25 Million USD | 7.954% |
| Alpha Teknova, Inc. | 45.85 Million USD | 83.435% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | 96.124% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | 83.064% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | 95.229% |
| Cosmos Health Inc. | 26.18 Million USD | 70.985% |
| Journey Medical Corporation | 54.59 Million USD | 86.086% |
| Embecta Corp. | 528.4 Million USD | 98.562% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | 97.206% |
| Dynavax Technologies Corporation | 219.14 Million USD | 96.534% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 98.712% |
| Pacira BioSciences, Inc. | 326.37 Million USD | 97.672% |
| PainReform Ltd. | 9.58 Million USD | 20.738% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | 42.12% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | 42.12% |
| SCYNEXIS, Inc. | 51.84 Million USD | 85.349% |
| Safety Shot Inc | 12.1 Million USD | 37.27% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -147.507% |
| Procaps Group, S.A. | 199.47 Million USD | 96.192% |
| Theratechnologies Inc. | 72.75 Million USD | 89.559% |
| Harrow Health, Inc. | 89.97 Million USD | 91.557% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | 19.58% |
| Biofrontera Inc. | 39.95 Million USD | 80.989% |
| DURECT Corporation | 43.71 Million USD | 82.623% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | 98.564% |
| Cronos Group Inc. | 96.7 Million USD | 92.145% |
| OptiNose, Inc. | 85.1 Million USD | 91.074% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | 96.727% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | 80.598% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 179.452% |
| Organogenesis Holdings Inc. | 314.13 Million USD | 97.582% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | 21.934% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | 82.35% |
| Radius Health, Inc. | 265.92 Million USD | 97.143% |
| Universe Pharmaceuticals INC | 13.84 Million USD | 45.12% |
| ProPhase Labs, Inc. | 37.85 Million USD | 79.931% |
| Phibro Animal Health Corporation | 260.29 Million USD | 97.082% |
| Procaps Group S.A. | 187.24 Million USD | 95.943% |
| Alvotech | 285.43 Million USD | 97.339% |
| TherapeuticsMD, Inc. | 9.82 Million USD | 22.682% |
| Viatris Inc. | 5.96 Billion USD | 99.873% |
| Rockwell Medical, Inc. | 15.37 Million USD | 50.589% |
| Aytu BioPharma, Inc. | 59.84 Million USD | 87.305% |
| SIGA Technologies, Inc. | 22.04 Million USD | 65.538% |
| Tilray Brands, Inc. | 251.35 Million USD | 96.978% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | 84.509% |
| Shineco, Inc. | 17.94 Million USD | 57.675% |
| PetIQ, Inc. | 192.72 Million USD | 96.058% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -90.333% |
| Incannex Healthcare Limited | 30.05 Million USD | 74.723% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 99.524% |
| Alimera Sciences, Inc. | 62.64 Million USD | 87.873% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -896.266% |
| Assertio Holdings, Inc. | 368.58 Million USD | 97.939% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | -29.069% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | 57.344% |
| Clever Leaves Holdings Inc. | 21.16 Million USD | 64.115% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | 63.899% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | 95.395% |
| Talphera, Inc. | 11.99 Million USD | 36.665% |
| Alvotech | 285.43 Million USD | 97.339% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | 94.601% |
| Lantheus Holdings, Inc. | 344.9 Million USD | 97.797% |
| Currenc Group, Inc. | 24 Million USD | 68.351% |
| Kamada Ltd. | 45.42 Million USD | 83.277% |
| Indivior PLC | 911 Million USD | 99.166% |
| Evoke Pharma, Inc. | 12.4 Million USD | 38.786% |
| Flora Growth Corp. | 10.57 Million USD | 28.193% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | 63.899% |
| Evolus, Inc. | 189.75 Million USD | 95.997% |
| HUTCHMED (China) Limited | 436.23 Million USD | 98.259% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | 95.072% |
| Akanda Corp. | 3.48 Million USD | -118.069% |